Evidence map›Paper›PMID 29370356›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2018

Moving Forward With Treatment of Gonorrhea for Users of Human Immunodeficiency Virus Preexposure Prophylaxis Given the Threat of Antimicrobial Resistance.

Samuel M Jenness, Kevin M Weiss, Steven M Goodreau, Thomas Gift, Harrell Chesson, Karen W Hoover, Dawn K Smith, Albert Y Liu, Patrick S Sullivan, Eli S Rosenberg

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Samuel M JennessDepartment of Epidemiology, Emory University, Atlanta, Georgia.
Kevin M WeissDepartment of Epidemiology, Emory University, Atlanta, Georgia.
Steven M GoodreauDepartment of Anthropology, University of Washington, Seattle.
Thomas GiftDivision of STD Prevention and Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Harrell ChessonDivision of STD Prevention and Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Karen W HooverDivision of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Dawn K SmithDivision of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Albert Y LiuSan Francisco Department of Public Health, California.
Patrick S SullivanDepartment of Epidemiology, Emory University, Atlanta, Georgia.
Eli S RosenbergDepartment of Epidemiology and Biostatistics, University at Albany School of Public Health, State University of New York.

Funding

Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Carlos del Rio · 2002 to 2026
$74.0M
ENHANCING MODELS OF HIV, VIRAL HEPATITIS, STIs, AND TUBERCULOSIS TO INFORM AND IMPROVE PUBLIC HEALTH IMPACTU38PS004646 · PS · EMORY UNIVERSITY · PI SULLIVAN, PATRICK · 2014 to 2015
$2.9M
Modeling Antiretroviral-Based Prevention among MSM in the USR21MH112449 · NIMH · EMORY UNIVERSITY · PI JENNESS, SAMUEL · 2017 to 2018
$442k
Intramural CDC HHS CC999999NCHHSTP CDC HHS U38 PS004646NIAID NIH HHS P30 AI050409NIMH NIH HHS R21 MH112449
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ChlamydiaGonorrheaPre-Exposure ProphylaxisSexual and Gender MinoritiesAnti-Bacterial AgentsDrug Resistance, BacterialHIVHomosexuality, MaleHumansIncidenceMaleAnti-Bacterial Agents

Identifiers

PMID29370356
PMCPMC6005146

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.